A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Mise à jour : Il y a 4 ans
Référence : NCT00550238

Femme et Homme

Extrait

To assess the long-term safety and tolerability of ACP-103 in subjects with Parkinson's disease psychosis.


Critère d'inclusion

  • Parkinson's Disease Psychosis